Myriad Genetics Sells Pharma Research Services Business to Q2 Solutions
The divestiture is part of Myriad's plan to restructure its business and get itself back on stronger financial footing.
Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay
Q2 Solutions will run Adaptive's NGS-based immune cell receptor profiling assay for its pharma and biotech clients, potentially in COVID-19 vaccine trials.
BC Platforms Closes $15M Series C Financing; Teams With IQvia
IQvia, the lead investor in this round, will work with BC Platforms to integrate genomic and clinical data in a secure environment to support biomedical research.
Now a subsidiary of IQvia, NLP vendor Linguamatics also is looking to help precision medicine providers and pharma researchers with phenotype-genotype matching.
The new IQvia E360 Genomics build includes a "privacy-preserving" database system and will soon have analytic tools to support genotype-phenotype research.